Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:138998777" >
High-risk chronic l...
High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies
-
Dreger, P (författare)
-
Ghia, P (författare)
-
Schetelig, J (författare)
-
visa fler...
-
van Gelder, M (författare)
-
- Kimby, E (författare)
- Karolinska Institutet
-
Michallet, M (författare)
-
Moreno, C (författare)
-
Robak, T (författare)
-
Stilgenbauer, S (författare)
-
Montserrat, E (författare)
-
visa färre...
-
(creator_code:org_t)
- American Society of Hematology, 2018
- 2018
- Engelska.
-
Ingår i: Blood. - : American Society of Hematology. - 1528-0020 .- 0006-4971. ; 132:9, s. 892-902
- Relaterad länk:
-
https://ashpublicati...
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- High-risk chronic lymphocytic leukemia (CLL) has been defined by clinical and/or genetic resistance (TP53 abnormalities) to treatment with chemoimmunotherapy (CIT). With the availability of pathway inhibitors (PIs), such as kinase inhibitors and BCL2 antagonists, the outlook of CIT-resistant patients has dramatically improved. Here, we propose a revision of the concept of high-risk CLL, driven by TP53 abnormalities and response to treatment with PI. CLL high-risk-I, CIT-resistant is defined by clinically CIT-resistant disease with TP53 aberrations, but fully responsive to PI. This category is largely the domain of PI-based therapy, and cellular therapy (ie, allogeneic hematopoietic cell transplantation) remains an option only in selected patients with low individual procedure-related risk. In CLL high-risk-II, CIT- and PI-resistant, characterized by increasing exhaustion of pharmacological treatment possibilities, cellular therapies (including chimeric antigen receptor-engineered T cells) should be considered in patients eligible for these procedures. Moreover, molecular and cellular therapies are not mutually exclusive and could be used synergistically to exploit their full potential.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Blood
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Dreger, P
-
Ghia, P
-
Schetelig, J
-
van Gelder, M
-
Kimby, E
-
Michallet, M
-
visa fler...
-
Moreno, C
-
Robak, T
-
Stilgenbauer, S
-
Montserrat, E
-
visa färre...
- Artiklar i publikationen
-
Blood
- Av lärosätet
-
Karolinska Institutet